The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Pediatric Sleep Apnea and CPAP

Diagnosis and CPAP-based management of obstructive sleep apnea in children for normal growth and development.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Çocuk Sağlığı ve Hastalıkları department. Book Appointment →

What is Pediatric Sleep Apnea and CPAP?

Pediatric obstructive sleep apnea (OSA) is upper airway collapse causing intermittent hypoxia, sleep fragmentation, and sympathetic activation; prevalence 1–4% in school-aged children.

Pathophysiology: predominantly anatomic (adenotonsillar hypertrophy in 70–90%) plus functional (decreased upper airway tone) leading to airway obstruction during sleep.

Severity classification by pediatric polysomnography: mild (AHI 1–5), moderate (AHI 5–10), severe (AHI >10) — different from adult thresholds.

Treatment hierarchy: adenotonsillectomy (first-line for adenotonsillar hypertrophy), CPAP (residual disease, contraindication to surgery, syndromic patients), oral appliances, weight loss, surgical alternatives.

Symptoms

Snoring (loud, frequent, often nightly)
Witnessed apneas, choking, gasping during sleep
Restless sleep, frequent awakenings, unusual sleep positions (head extended, neck hyperextended)
Mouth breathing, dry mouth, throat soreness in morning
Excessive daytime sleepiness (less common in children than adults)
Behavioral problems: hyperactivity, attention difficulties, learning problems, ADHD-like symptoms
Mood disturbance: irritability, depression, anxiety
Headache (especially morning)
Bedwetting (resurgence of toilet training in toilet-trained children)
Failure to thrive, growth retardation in severe disease
Cardiovascular: hypertension (rare but possible), pulmonary hypertension, cor pulmonale (severe untreated cases)

Risk Factors

Adenotonsillar hypertrophy (most common cause)
Obesity (BMI >95th percentile)
Craniofacial abnormalities: micrognathia, retrognathia, midface hypoplasia
Down syndrome (50–80% prevalence)
Other genetic syndromes: Pierre Robin sequence, Treacher Collins, achondroplasia, Prader-Willi syndrome
Neuromuscular disease (cerebral palsy, muscular dystrophy)
Allergic rhinitis, chronic sinusitis (nasal obstruction)
Family history of OSA
Male sex (slight predominance in adolescents)
Tobacco smoke exposure
Premature birth

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Loud snoring with witnessed apneas or pauses in breathing
  • Restless sleep, frequent awakenings, unusual sleep positions
  • Excessive daytime sleepiness, school problems, behavioral issues
  • Bedwetting recurrence in toilet-trained children
  • Failure to thrive or growth concerns with sleep symptoms
  • Down syndrome or other syndromic patients require routine OSA screening
  • Persistent or worsening symptoms despite adenotonsillectomy
  • Postoperative concerns: recurring snoring, persistent sleepiness

Treatment Methods

01
Initial assessment: detailed sleep history, physical examination (tonsil size, nasal anatomy, craniofacial features, BMI), Pediatric Sleep Questionnaire
02
Polysomnography (gold standard): in-laboratory overnight study with EEG, EOG, EMG, ECG, respiratory effort, airflow, oxygen saturation; obtain age-appropriate norms
03
Home sleep apnea testing: limited role in pediatric population, available for selected cases
04
Adenotonsillectomy (first-line treatment): 80–90% cure rate in healthy children with adenotonsillar hypertrophy; postoperative polysomnography recommended for persistent symptoms or high-risk patients
05
CPAP indications: residual OSA after adenotonsillectomy, contraindication to surgery, severe craniofacial abnormalities, mild OSA without anatomic obstruction, obesity-related OSA, syndromic patients
06
CPAP titration: laboratory-based titration to determine optimal pressure (usually 4–10 cmH2O); auto-titrating devices (APAP) increasingly used
07
Mask interface selection: nasal mask preferred for younger children, full-face mask for mouth breathers, nasal pillows for older children/adolescents; sizing critical for compliance
08
BiPAP (bilevel positive airway pressure): for children intolerant of CPAP, neuromuscular disease, complex sleep apnea, hypoventilation syndromes
09
Adherence support: behavioral therapy (desensitization, gradual introduction), age-appropriate education, parent training, regular follow-up; adherence 50–70% in children
10
Adjunctive therapy: nasal saline, intranasal corticosteroids, leukotriene receptor antagonists (montelukast) for residual mild OSA
11
Weight management: weight loss program for obese children with OSA; lifestyle modification, dietary counseling, exercise
12
Orthodontic interventions: rapid maxillary expansion (RME) for children with maxillary deficiency; mandibular advancement devices in selected adolescents
13
Surgical alternatives: lingual tonsillectomy, supraglottoplasty, mandibular advancement, distraction osteogenesis, tracheostomy (severe refractory cases)
14
Follow-up after CPAP initiation: monthly compliance review (download data), pressure adjustment, mask refitting, growth and behavior assessment, school performance review
15
Long-term polysomnography: every 1–2 years to reassess therapy efficacy, especially during growth spurts and weight changes
16
Comorbid management: ADHD, learning difficulties, behavior problems often improve with effective OSA treatment
17
Nutritional and growth support: monitoring growth parameters, addressing failure to thrive, dietary optimization
18
Family-centered care: parent education, sibling support, school coordination, peer interaction support
19
Long-term outcomes: significant improvement in sleep quality, behavioral and cognitive functioning, growth and quality of life with effective treatment
20
Multidisciplinary follow-up: pediatric pulmonology, otolaryngology, sleep medicine, dental services, nutrition, behavioral health, primary care

Which Department to Visit?

You can visit our Çocuk Sağlığı ve Hastalıkları department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Çocuk Sağlığı ve Hastalıkları Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Regular Gynecological Check-up

Kadın Hastalıkları ve Doğum

Regular gynecological check-ups enable early diagnosis of many women's diseases and increase treatment success. It is recommended that every sexually active woman or woman over 21 see a gynecologist at least once a year.

Cervical Cancer

Kadın Hastalıkları ve Doğum

Cervical cancer develops from uncontrolled growth of cells in the cervix and is among the most common women's cancers worldwide. Precancerous lesions can be recognized with regular Pap smear and HPV testing.

HPV and Vaccination

Kadın Hastalıkları ve Doğum

HPV is a common virus transmitted sexually that can lead to certain types of cancer. Vaccination provides over 90% protection against high-risk HPV strains.

Ovarian Cyst

Kadın Hastalıkları ve Doğum

Ovarian cysts are fluid-filled sacs that form in or on the ovarian tissue. Most are asymptomatic and disappear spontaneously; however, large or complex cysts can cause pain and complications.

Endometriosis

Kadın Hastalıkları ve Doğum

Endometriosis affects about 10% of women of reproductive age, causing cyclic pelvic pain, dysmenorrhea, dyspareunia, and infertility; combined medical and laparoscopic treatment improves quality of life.

Uterine Fibroids

Kadın Hastalıkları ve Doğum

Uterine fibroids are benign tumors developing from the uterine muscle layer. They affect 20-50% of women of reproductive age; most are asymptomatic, but can cause bleeding and pain.

Polycystic Ovary Syndrome (PCOS)

Kadın Hastalıkları ve Doğum

PCOS is the most common endocrine disease affecting approximately 10% of women of reproductive age, characterized by androgen excess, ovulation disorder, and polycystic ovarian appearance.

Menopause

Kadın Hastalıkları ve Doğum

Menopause is the life stage defined by not having a period for 12 consecutive months and the natural cessation of ovarian function. The average age is 51, but it can vary between 45-55 years.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.